Literature DB >> 24721319

Involvement of mannose-binding lectin in the pathogenesis of Kawasaki disease-like murine vasculitis.

Akihiro Nakamura1, Mitsuhiko Okigaki2, Noriko Miura3, Chinatsu Suzuki4, Naohito Ohno3, Fuyuki Kametani5, Kenji Hamaoka4.   

Abstract

Kawasaki disease (KD) is a paediatric idiopathic vasculitis. In this study, on the basis of studies using an established animal model for KD, we report that mannose-binding lectin (MBL) is involved in the pathogenesis of the disease. KD-like experimental murine vasculitis was induced by intraperitoneally administering a Candida albicans water-soluble extract (CAWS). MBL-A gradually increased in the serum of the model mice treated with CAWS. Deposition of MBL-A and MBL-C was observed in the aortic root, including the coronary arteries, which is a predilection site in experimental vasculitis. Corresponding to the distribution patterns of MBLs, marked deposition of C3/C3-derived peptides was also observed. Regarding the self-reactivity of MBLs, we observed that MBLs interacted with core histones to activate the lectin pathway. These results suggest that some types of pathogens provoke the MBL-dependent complement pathway (lectin pathway) to cause and/or exacerbate KD-like vasculitis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal model; Kawasaki disease;; Mannose-binding lectin;; Vasculitis;

Mesh:

Substances:

Year:  2014        PMID: 24721319     DOI: 10.1016/j.clim.2014.03.019

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

1.  Early decreased plasma levels of factor B and C5a are important biomarkers in children with Kawasaki disease.

Authors:  Qing-Mei Zou; Xiao-Hui Li; Rui-Xia Song; Nan-Ping Xu; Ting Zhang; Ming-Ming Zhang; Yao Lin; Lin Shi; Jin Fu; Xiao-Dai Cui
Journal:  Pediatr Res       Date:  2015-05-04       Impact factor: 3.756

2.  Mannose-binding lectin (MBL) codon 54 (rs1800450) polymorphism predisposes towards medium vessel vasculitis in patients with systemic lupus erythematosus.

Authors:  Vir Singh Negi; Panneer Devaraju; Durga Prasanna Misra; Vikramraj K Jain; Jignesh Babulal Usdadiya; Paul T Antony; Reena Gulati
Journal:  Clin Rheumatol       Date:  2017-01-17       Impact factor: 2.980

3.  Plasma MASP-1 concentration and its relationship to recovery from coronary artery lesion in children with Kawasaki disease.

Authors:  Rui-Xia Song; Qing-Mei Zou; Xiao-Hui Li; Nan-Ping Xu; Ting Zhang; Jin Fu; Xiao-Dai Cui
Journal:  Pediatr Res       Date:  2015-11-04       Impact factor: 3.756

Review 4.  Kawasaki disease: pathophysiology and insights from mouse models.

Authors:  Magali Noval Rivas; Moshe Arditi
Journal:  Nat Rev Rheumatol       Date:  2020-05-26       Impact factor: 20.543

5.  Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?

Authors:  Anastasia Polycarpou; Sofia Grigoriadou; Linda Klavinskis; Steven Sacks
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

6.  CDCP1 on Dendritic Cells Contributes to the Development of a Model of Kawasaki Disease.

Authors:  Yu Lun; Nozha Borjini; Noriko N Miura; Naohito Ohno; Nora G Singer; Feng Lin
Journal:  J Immunol       Date:  2021-06-07       Impact factor: 5.426

Review 7.  Vasculitides and the Complement System: a Comprehensive Review.

Authors:  Maria Sole Chimenti; Eleonora Ballanti; Paola Triggianese; Roberto Perricone
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 10.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.